Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis after Concurrent Chemoradiation Therapy

Locally advanced hepatocellular carcinoma (HCC) with portal vein thrombosis carries a 1-year survival rate <10%. Localized concurrent chemoradiotherapy (CCRT), followed by hepatic arterial infusion chemotherapy (HAIC), was recently introduced in this setting. Here, we report our early experience...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Yonsei Med J
Asıl Yazarlar: Han, Dai Hoon, Joo, Dong Jin, Kim, Myoung Soo, Choi, Gi Hong, Choi, Jin Sub, Park, Young Nyun, Seong, Jinsil, Han, Kwang-Hyub, Kim, Soon Il
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Yonsei University College of Medicine 2016
Konular:
Brief Communication
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4960397/
https://ncbi.nlm.nih.gov/pubmed/27401662
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2016.57.5.1276
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller